about
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment OptionsThe aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27.Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells.Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cellsIL-27 Induces Th17 Differentiation in the Absence of STAT1 SignalingNogo-A downregulation improves insulin secretion in mice.Metallothioneins negatively regulate IL-27-induced type 1 regulatory T-cell differentiation.Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cellsAryl hydrocarbon receptor controls regulatory CD4+ T cell function.EBI2 Expression and Function: Robust in Memory Lymphocytes and Increased by Natalizumab in Multiple Sclerosis.SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth.Combined antiviral-immunosuppressive treatment in human T-lymphotrophic virus 1-Sjögren-associated myelopathy.Human herpesvirus-6 variant A encephalomyelitis.Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patientsIL-27-Induced Type 1 Regulatory T-Cells Produce Oxysterols that Constrain IL-10 Production.Oxysterols regulate encephalitogenic CD4(+) T cell trafficking during central nervous system autoimmunity.Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease.Synaptic destabilization by neuronal Nogo-A.Ag-Presenting CpG-Activated pDCs Prime Th17 Cells That Induce Tumor RegressionThe "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T studyOxysterols in AutoimmunityPatterns of care for Multiple Sclerosis in a setting of universal care access: A cross-sectional studyDisrupting Myelin-Specific Th17 Cell Gut Homing Confers Protection in an Adoptive Transfer Experimental Autoimmune EncephalomyelitisThe disease burden of Multiple Sclerosis from the individual and population perspective: Which symptoms matter most?Resolution of inflammation during multiple sclerosisThe EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitisHuman Leukocyte Antigen Genotype as a Marker of Multiple Sclerosis PrognosisHow do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis
P50
Q28601505-909E578E-0608-4283-B66B-2B447F8A6D1BQ34131656-D827EA47-5E16-421B-A445-804707E24C01Q34242160-2121D72B-C07A-480B-AC74-99B542490F4BQ34609504-0CD20B3A-945B-418F-9811-1DBAD180CBE0Q36177032-9032AF59-3EEB-4150-BD6D-417348F35B1FQ36795953-B78494C6-BB48-4230-8C12-F8D1EDB1FD4BQ36835441-061A3883-AF45-41E2-AC8A-BC39F7188989Q37242180-569036D4-56E9-48E3-95A3-F0A79A5566ACQ38015276-1369D289-8A50-4D01-A2CE-9A9600FD6D3DQ39041037-2D4698C8-7816-4417-9F8E-016B26C31B29Q39160299-5510F739-B0A8-41EA-A783-050E03667CA7Q39365276-AFB56870-B2F0-47C5-A645-2BB2B020EB01Q40424302-3559605C-1459-409B-BBB7-6B8980976AD1Q41112107-932DBF63-D816-4AB6-A603-A1A288B606EFQ41921187-6E641451-9F0F-4B43-9CC5-9C8BEA29563DQ42178118-5C14537F-0041-47E2-8842-9BE530C1647EQ45236771-D3AF5825-754A-475C-9D30-0647049F0936Q51974331-513417CE-D611-46E6-A650-4AC56ED86BBFQ63190402-159B7990-678B-4EB6-A537-6DE54BC5E408Q90178199-9E13A48A-5B5B-4DF6-A1D9-1090EB36A3ACQ90230131-9073ED4F-8A37-41DC-B85B-A2C127126DA9Q90361712-D3B02EF0-468B-4FA5-B9F3-BAB1F5F2C6F6Q90612374-DFB7C3F7-306F-4D3C-9438-766E09A54084Q90614254-F63925B8-F4EC-403F-9BD0-EBDB6FF6AF46Q91303211-7345471E-52C7-4436-9DC0-7360BAEA4F2AQ91451009-7773A897-A99E-4774-804B-E67329A1280FQ91578390-B2A457BD-6FD1-4F77-A135-EA3D23BC5565Q92919256-B9BF18DF-22EC-4640-A02B-7124EC686037
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Caroline Pot
@ast
Caroline Pot
@en
Caroline Pot
@es
Caroline Pot
@nl
Caroline Pot
@sl
type
label
Caroline Pot
@ast
Caroline Pot
@en
Caroline Pot
@es
Caroline Pot
@nl
Caroline Pot
@sl
prefLabel
Caroline Pot
@ast
Caroline Pot
@en
Caroline Pot
@es
Caroline Pot
@nl
Caroline Pot
@sl
P108
P106
P1153
22938753500
P21
P31
P496
0000-0002-1146-3129